AU2002310073A1 - Delivery of physiologically active compounds through an inhalation route - Google Patents

Delivery of physiologically active compounds through an inhalation route

Info

Publication number
AU2002310073A1
AU2002310073A1 AU2002310073A AU2002310073A AU2002310073A1 AU 2002310073 A1 AU2002310073 A1 AU 2002310073A1 AU 2002310073 A AU2002310073 A AU 2002310073A AU 2002310073 A AU2002310073 A AU 2002310073A AU 2002310073 A1 AU2002310073 A1 AU 2002310073A1
Authority
AU
Australia
Prior art keywords
delivery
active compounds
physiologically active
inhalation route
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002310073A
Inventor
Joshua D. Rabinowitz
Alejandro C. Zaffaroni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexza Pharmaceuticals Inc
Original Assignee
Alexza Molecular Delivery Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexza Molecular Delivery Corp filed Critical Alexza Molecular Delivery Corp
Publication of AU2002310073A1 publication Critical patent/AU2002310073A1/en
Abandoned legal-status Critical Current

Links

AU2002310073A 2001-05-24 2002-05-23 Delivery of physiologically active compounds through an inhalation route Abandoned AU2002310073A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/294,203 2001-05-24
US60/317,479 2001-09-05

Publications (1)

Publication Number Publication Date
AU2002310073A1 true AU2002310073A1 (en) 2002-12-03

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002363947A1 (en) Delivery of caffeine through an inhalation route
AU2002322719A1 (en) Delivery of therapeutic capable agents
AU2003239433A1 (en) Delivery of drug amines through an inhalation route
AU2002234476A1 (en) Medical aerosol formulations
AU2002361453A1 (en) Metered dose inhaler
AU2001248673A1 (en) Nasal inhaler
WO2002089880A8 (en) Inhalers
AU2002342050A1 (en) Anesthesia drug monitor
AU2002246925A1 (en) Therapeutic delivery balloon
AU2002352344A1 (en) Medicament delivery assembly
EP1392241A4 (en) System for osmotic delivery of pharmaceutically active agents
AU2002247280A1 (en) Ocular drug delivery nebulizer
EE200300501A (en) Formulations of imidazotriazinone for nasal administration
AU2002346143A1 (en) Compositions for nasal administration of insulin
MXPA03005980A (en) Compositions for nasal administration of insulin.
AU2002348971A1 (en) Ph-sensitive liposomes for targeted drug delivery
AU2002240942A1 (en) Improved delivery of benefit agents
AUPR277401A0 (en) Physiologically active bracing
AU2002310073A1 (en) Delivery of physiologically active compounds through an inhalation route
AU2001260281A1 (en) Medicament for combating respiratory depression
AU2002229932A1 (en) Delivery of biologically active agents
AU2001274236A1 (en) Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrinantagonist
AU2002305682A1 (en) Delivery of diphenhydramine through an inhalation route
AU2002259259A1 (en) Delivery of antidepressants through an inhalation route
AU2002315056A1 (en) Delivery of drug esters through an inhalation route